Stock Analiz

Enanta Pharmaceuticals Inc. (ENTA) stock forecast and price target

Price $10.99 · data as of November 13, 2026

12-month price target

Average target$21.83
Upside / downside+98.7%
Analysts6
ConsensusNone
Low $19.00Average $21.83High $32.00

Gold marker: average target · white marker: today’s price ($10.99)

Analyst ratings

Strong buy 1Buy 5Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Next fiscal year
ends September 30, 2027
$-2.37−3.6%$64M
Quarter after
ends December 31, 2026
$-0.41+3.6%$16M

Consensus of the analysts covering Enanta Pharmaceuticals, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Frequently asked questions

What is the Enanta Pharmaceuticals stock price target?

The average 12-month target from 6 analysts is $21.83, 98.7% above the current price of $10.99 Targets range from $19.00 to $32.00.

Is Enanta Pharmaceuticals a buy according to analysts?

The consensus rating is “None” (1 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.